108 related articles for article (PubMed ID: 12738906)
21. [Central nervous system involvement of leukemia and systemic lymphoma in children: CT and MR findings].
Tomura N; Hirano H; Kato K; Sashi R; Hashimoto M; Watarai J; Watanabe A
No To Shinkei; 1997 Nov; 49(11):993-1000. PubMed ID: 9396030
[TBL] [Abstract][Full Text] [Related]
22. Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma.
Rodriguez M
Acta Radiol Suppl; 1998; 417():1-36. PubMed ID: 9645167
[TBL] [Abstract][Full Text] [Related]
23. Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma.
Maggialetti N; Ferrari C; Minoia C; Asabella AN; Ficco M; Loseto G; De Tullio G; de Fazio V; Calabrese A; Guarini A; Rubini G; Brunese L
Radiol Med; 2016 Feb; 121(2):132-43. PubMed ID: 26349573
[TBL] [Abstract][Full Text] [Related]
24. [Computer tomographic and sonographic diagnosis and control in malignant lymphoma of the stomach].
Crone-Münzebrock W; Brockmann WP
Rofo; 1983 Dec; 139(6):676-80. PubMed ID: 6421699
[TBL] [Abstract][Full Text] [Related]
25. [Relevance of magnetic resonance imaging for the staging and follow up of lymph node pathologies in adults with primary malignant lymphomas].
Michna G; Ghanem N; Laubenberger J; Schneider B; Kromeier J; Langer M
Radiologe; 2002 Dec; 42(12):993-9. PubMed ID: 12486553
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
Tsuji K; Kishi S; Tsuchida T; Yamauchi T; Ikegaya S; Urasaki Y; Fujiwara Y; Ueda T; Okazawa H; Kimura H
J Magn Reson Imaging; 2015 Jun; 41(6):1601-7. PubMed ID: 25111444
[TBL] [Abstract][Full Text] [Related]
27. Contribution of computed tomography to the treatment of lymphomas.
Pilepich MV; Rene JB; Munzenrider JE; Carter BL
AJR Am J Roentgenol; 1978 Jul; 131(1):69-73. PubMed ID: 97988
[TBL] [Abstract][Full Text] [Related]
28. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
30. PET/CT, MR, and PET/MR in Lymphoma and Melanoma.
Schwenzer NF; Pfannenberg AC
Semin Nucl Med; 2015 Jul; 45(4):322-31. PubMed ID: 26050659
[TBL] [Abstract][Full Text] [Related]
31. [Magnetic resonance imaging in the staging of malignant lymphomas].
Mikhaĭlov AI; Tiurin IE; Panov VO
Vestn Rentgenol Radiol; 2014; (2):60-7. PubMed ID: 25272725
[TBL] [Abstract][Full Text] [Related]
32. [A case of isolated hepatic malignant lymphoma representing characteristic findings on radiological imaging].
Yamamoto N; Nishie A; Yoshimitsu K; Irie H; Aibe H; Tajima T; Asayama Y; Matake K; Nakayama T; Kakihara D; Ohga S; Nakamura K; Honda H
Fukuoka Igaku Zasshi; 2003 Nov; 94(11):319-22. PubMed ID: 14752938
[TBL] [Abstract][Full Text] [Related]
33. Breast lymphoma: imaging findings of 32 tumors in 27 patients.
Yang WT; Lane DL; Le-Petross HT; Abruzzo LV; Macapinlac HA
Radiology; 2007 Dec; 245(3):692-702. PubMed ID: 17911538
[TBL] [Abstract][Full Text] [Related]
34. The role of abdominal computed tomography in lymphoma following treatment.
Blackledge G; Mamtora H; Crowther D; Isherwood I; Best JJ
Br J Radiol; 1981 Nov; 54(647):955-60. PubMed ID: 7306766
[TBL] [Abstract][Full Text] [Related]
35. Imaging of primary and secondary renal lymphoma.
Ganeshan D; Iyer R; Devine C; Bhosale P; Paulson E
AJR Am J Roentgenol; 2013 Nov; 201(5):W712-9. PubMed ID: 24147501
[TBL] [Abstract][Full Text] [Related]
36. [Lymphoma-like course in aggressive adult multisystem Langerhans cell histiocytosis and the benefit of PET/CT imaging in evaluation of diffuse metabolic activity of lung parenchyma].
Szturz P; Adam Z; Rehák Z; Koukalová R; Kodet R; Nebeský T; Neubauer J; Moulis M; Smardová L; Mayer J
Vnitr Lek; 2010 Nov; 56(11):1177-93. PubMed ID: 21250497
[TBL] [Abstract][Full Text] [Related]
37. New imaging techniques in staging lymphomas.
Musumeci R; Tesoro-Tess JD
Curr Opin Oncol; 1994 Sep; 6(5):464-9. PubMed ID: 7827148
[TBL] [Abstract][Full Text] [Related]
38. Little value of surveillance magnetic resonance imaging for primary CNS lymphomas in first remission: results from a Danish Multicentre Study.
Mylam KJ; Michaelsen TY; Hutchings M; Jacobsen Pulczynski E; Pedersen LM; Braendstrup P; Gade IL; Eberlein TR; Gang AO; Bøgsted M; Brown PN; El-Galaly TC
Br J Haematol; 2017 Feb; 176(4):671-673. PubMed ID: 26913572
[No Abstract] [Full Text] [Related]
39. Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain.
Ogawa T; Kanno I; Hatazawa J; Inugami A; Fujita H; Shimosegawa E; Murakami M; Okudera T; Uemura K; Yasui N
Radiographics; 1994 Jan; 14(1):101-10. PubMed ID: 8128041
[TBL] [Abstract][Full Text] [Related]
40. Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma.
Gu J; Chan T; Zhang J; Leung AY; Kwong YL; Khong PL
AJR Am J Roentgenol; 2011 Sep; 197(3):W384-91. PubMed ID: 21862763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
